Neurovascular Stents-Medical Devices Pipeline Assessment, 2017

Neurovascular Stents-Medical Devices Pipeline Assessment, 2017


  • Products Id :- GDME0345EPD
  • |
  • Pages: 70
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Neurovascular Stents-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Neurovascular Stents-Medical Devices Pipeline Assessment, 2017" provides an overview of Neurovascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurovascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Neurovascular Stents under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Neurovascular Stents and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Neurovascular Stents under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Neurovascular Stents Overview 6

3 Products under Development 7

3.1 Neurovascular Stents-Pipeline Products by Stage of Development 7

3.2 Neurovascular Stents-Pipeline Products by Territory 8

3.3 Neurovascular Stents-Pipeline Products by Regulatory Path 9

3.4 Neurovascular Stents-Pipeline Products by Estimated Approval Date 10

3.5 Neurovascular Stents-Ongoing Clinical Trials 11

4 Neurovascular Stents-Pipeline Products under Development by Companies 12

4.1 Neurovascular Stents Companies-Pipeline Products by Stage of Development 12

4.2 Neurovascular Stents-Pipeline Products by Stage of Development 13

5 Neurovascular Stents Companies and Product Overview 14

5.1 Aneuclose LLC Company Overview 14

5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Apeliotus Technologies Company Overview 15

5.2.1 Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 15

5.3 Codman & Shurtleff Inc Company Overview 16

5.3.1 Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 16

5.4 Cordis Corp Company Overview 18

5.4.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 Gaudi Vascular, Inc. Company Overview 19

5.5.1 Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

5.6 MicroPort Scientific Corp Company Overview 20

5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 20

5.7 MicroVention, Inc. Company Overview 21

5.7.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

5.8 Neurosigma Inc Company Overview 25

5.8.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.9 NSVascular, Inc. Company Overview 26

5.9.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 Palmaz Scientific Inc Company Overview 27

5.10.1 Palmaz Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 28

5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 28

5.12 University of California Los Angeles Company Overview 29

5.12.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 29

6 Neurovascular Stents- Recent Developments 30

6.1 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 30

6.2 Apr 23, 2017: Bard Announces First Quarter Results 31

6.3 Mar 30, 2017: MPSC Announces 2016 Annual Results 31

6.4 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 33

6.5 Feb 16, 2017: InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 36

6.6 Feb 14, 2017: MicroPort Receives CFDA Approval for APOLLO Intracranial Stent System in Large Sizes 37

6.7 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 38

6.8 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 38

6.9 Jan 26, 2017: Bard Announces Fourth Quarter Results 40

6.10 Dec 15, 2016: MicroPort NeuroTech Attends CINS 2016 40

6.11 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 41

6.12 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 44

6.13 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 44

6.14 Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 45

6.15 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 47

6.16 Oct 25, 2016: Bard Announces Third Quarter Results 49

6.17 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 50

6.18 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 50

6.19 Sep 07, 2016: InspireMD Appoints Thomas Kester to Board of Directors 51

6.20 Aug 30, 2016: MPSC Announces 2016 Interim Results 52

6.21 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 53

6.22 Aug 09, 2016: InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 56

6.23 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 58

6.24 Jul 26, 2016: Bard Announces Second Quarter Results 60

6.25 Jul 21, 2016: InspireMD Regains Compliance With NYSE MKT Listing Standards 61

6.26 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 61

6.27 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 61

6.28 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 62

6.29 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 62

6.30 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 63

7 Appendix 67

7.1 Methodology 67

7.2 About GlobalData 70

7.3 Contact Us 70

7.4 Disclaimer 70

1.2 List of Figures

Figure 1: Neurovascular Stents-Pipeline Products by Stage of Development 7

Figure 2: Neurovascular Stents-Pipeline Products by Territory 8

Figure 3: Neurovascular Stents-Pipeline Products by Regulatory Path 9

Figure 4: Neurovascular Stents-Pipeline Products by Estimated Approval Date 10

Figure 5: Neurovascular Stents-Ongoing Clinical Trials 11

1.1 List of Tables

Table 1: Neurovascular Stents-Pipeline Products by Stage of Development 7

Table 2: Neurovascular Stents-Pipeline Products by Territory 8

Table 3: Neurovascular Stents-Pipeline Products by Regulatory Path 9

Table 4: Neurovascular Stents-Pipeline Products by Estimated Approval Date 10

Table 5: Neurovascular Stents-Ongoing Clinical Trials 11

Table 6: Neurovascular Stents Companies-Pipeline Products by Stage of Development 12

Table 7: Neurovascular Stents-Pipeline Products by Stage of Development 13

Table 8: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: Aneurysm Occlusion Saddle-Product Status 14

Table 10: Aneurysm Occlusion Saddle-Product Description 14

Table 11: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 15

Table 12: Polymer Stent for Cerebral Aneurysms-Product Status 15

Table 13: Polymer Stent for Cerebral Aneurysms-Product Description 15

Table 14: Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Table 15: Covered Stent-Product Status 16

Table 16: Covered Stent-Product Description 16

Table 17: Next Generation Balloon Expandable Stent-Product Status 16

Table 18: Next Generation Balloon Expandable Stent-Product Description 17

Table 19: Self-Expanding Stent-Product Status 17

Table 20: Self-Expanding Stent-Product Description 17

Table 21: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 18

Table 22: Flow Diverter-Product Status 18

Table 23: Flow Diverter-Product Description 18

Table 24: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

Table 25: Intracranial Stent-Product Status 19

Table 26: Intracranial Stent-Product Description 19

Table 27: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 20

Table 28: Vertebral Artery Stent-Product Status 20

Table 29: Vertebral Artery Stent-Product Description 20

Table 30: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

Table 31: Coated Stent-Product Status 21

Table 32: Coated Stent-Product Description 21

Table 33: FRED Flow-Diverting Stent-Product Status 22

Table 34: FRED Flow-Diverting Stent-Product Description 22

Table 35: MicroVention, Inc.-Ongoing Clinical Trials Overview 23

Table 36: FRED Flow-Diverting Stent-Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms 24

Table 37: Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 38: Thin Film Nitinol Flow Diverting Stent-Product Status 25

Table 39: Thin Film Nitinol Flow Diverting Stent-Product Description 25

Table 40: NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

Table 41: Flow-Diverting TFN Stent-Product Status 26

Table 42: Flow-Diverting TFN Stent-Product Description 26

Table 43: Palmaz Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Table 44: Micro Neuro-Stent-Product Status 27

Table 45: Micro Neuro-Stent-Product Description 27

Table 46: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 28

Table 47: Flow Diversion Intracranial Stent-Product Status 28

Table 48: Flow Diversion Intracranial Stent-Product Description 28

Table 49: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 29

Table 50: Dual Rotational Stent-Product Status 29

Table 51: Dual Rotational Stent-Product Description 29

Table 52: Glossary 69

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Aneuclose LLC, Apeliotus Technologies, Codman & Shurtleff Inc, Cordis Corp, Gaudi Vascular, Inc., MicroPort Scientific Corp, MicroVention, Inc., Neurosigma Inc, NSVascular, Inc., Palmaz Scientific Inc, Sree Chitra Tirunal Institute for Medical Sciences & Technology, University of California Los Angeles

Aneuclose LLC, Aneurysm Occlusion Saddle; Apeliotus Technologies, Polymer Stent for Cerebral Aneurysms; Codman &; Shurtleff Inc, Covered Stent; Codman &; Shurtleff Inc, Next Generation Balloon Expandable Stent; Codman &; Shurtleff Inc, Self-Expanding Stent; Cordis Corp, Flow Diverter; Gaudi Vascular, Inc., Intracranial Stent; MicroPort Scientific Corp, Vertebral Artery Stent; MicroVention, Inc., Coated Stent; MicroVention, Inc., FRED Flow-Diverting Stent; Neurosigma Inc, Thin Film Nitinol Flow Diverting Stent; NSVascular, Inc., Flow-Diverting TFN Stent; Palmaz Scientific Inc, Micro Neuro-Stent; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Flow Diversion Intracranial Stent; University of California Los Angeles, Dual Rotational Stent

select a license

Single User License
USD 2500 INR 162625
Site License
USD 5000 INR 325250
Corporate User License
USD 7500 INR 487875

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com